Growing tobacco consumption is supporting expansion in the locally advanced pancreatic cancer market
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
From Its 2026 Market Size, What Value Is The Locally Advanced Pancreatic Cancer Market Projected To Reach By 2030?
The market for locally advanced pancreatic cancer has witnessed substantial growth over recent years. This market is projected to expand from $1.05 billion in 2025 to $1.16 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.5%. Factors contributing to this historical growth include the prevalence of late-stage diagnosis of pancreatic cancer, restricted surgical eligibility for locally advanced cases, a past dependence on gemcitabine-based chemotherapy, low overall survival rates, and an increase in hospital-based oncology care.
The market for locally advanced pancreatic cancer is projected to experience swift expansion over the coming years. This market is anticipated to reach $1.71 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.2%. Several factors are fueling this growth during the projection period, including the broadening of combination therapy protocols, the greater acceptance of SBRT, heightened investment in pancreatic cancer research, an intensifying focus on tailored oncology care, and the increasing presence of specialized treatment facilities. Key developments expected during this forecast period encompass the augmented use of combination chemotherapy regimens, an expanding embrace of neoadjuvant treatment methods, a heightened emphasis on reducing tumor size for surgical suitability, the wider application of radiation therapy for managing local disease, and a stronger focus on collaborative treatment strategies.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21214&type=smp
What Key Factors Are Affecting The Locally Advanced Pancreatic Cancer Market Demand?
Future expansion in the locally advanced pancreatic cancer markets is anticipated to be propelled by the rise in tobacco consumption. Tobacco is a plant with leaves processed into items like cigarettes and cigars. This plant contains addictive nicotine, associated with severe health problems including cancer and heart disease. The growing use of tobacco stems from various factors, namely its ready availability, reasonable cost, marketing strategies, cultural acceptance in certain regions, and smoking in response to stress. Consumption of tobacco poses a substantial risk for developing locally advanced pancreatic cancer, leading to a higher occurrence of pancreatic malignancies. For example, an October 2024 study on youth smoking trends by the European Respiratory Society’s (ERS), a Switzerland-based non-profit, showed a notable increase in smoking prevalence, with 22.5% of respondents smoking in 2022 rising to 40.1% in 2024. Consequently, the surge in tobacco consumption is fueling the expansion of the locally advanced pancreatic cancer market.
Which Segment Classifications Are Used In The Locally Advanced Pancreatic Cancer Market Segment Analysis?
The locally advanced pancreatic cancer market covered in this report is segmented –
1) By Therapy: Chemotherapy, Radiation Therapy
2) By Route Of Administration: Oral, Injectables, Other Routes Of Administrations
3) By End-User: Hospital, Specialty Clinics, Research Institutions, Other End-Users
Subsegments:
1) By Chemotherapy: Gemcitabine-based Chemotherapy, FOLFIRINOX Chemotherapy
2) By Radiation Therapy: External Beam Radiation Therapy, Stereotactic Body Radiation Therapy (SBRT)
What Trends Are Influencing Changes In The Locally Advanced Pancreatic Cancer Market?
Leading companies in the locally advanced pancreatic cancer market are concentrating on creating innovative products, such as orphan drugs, to improve treatment options, enhance patient outcomes, and address the unmet medical needs associated with this aggressive disease. Orphan drugs are specifically developed to treat rare conditions affecting a small number of individuals, and authorities provide incentives like tax reductions and market exclusivity to encourage their development. For instance, in January 2025, Actuate Therapeutics Inc., a US-based biopharmaceutical company, announced that its Elraglusib, a new GSK-3ß inhibitor, received Orphan Drug Designation from both the European Medicines Agency (EMA) and US Food and Drug Administration (FDA) for the treatment of pancreatic ductal adenocarcinoma (PDAC), a potential type of locally advanced pancreatic cancer. This recognition emphasizes its potential to fulfill a vital need in treating this severe cancer, especially given the promising Phase 2 trial results that showed significant clinical improvements and anti-tumor effects in metastatic PDAC patients.
Which Firms Are Contributing To The Locally Advanced Pancreatic Cancer Market Ecosystem?
Major companies operating in the locally advanced pancreatic cancer market are Pfizer Inc, F Hoffmann La Roche Ltd, Merck and Co Inc, Bristol Myers Squibb Company, AstraZeneca plc, AbbVie Inc, Novartis AG, GSK plc, Bayer AG, Eli Lilly and Company, Ipsen, Takeda Pharmaceutical Company Limited, Amgen Inc, Sanofi, Servier, NovoCure Limited, Halozyme Therapeutics, Clovis Oncology, Astellas Pharma, BeiGene
Get The Full Locally Advanced Pancreatic Cancer Market Report:
Where Is The Locally Advanced Pancreatic Cancer Market Primarily Concentrated By Region?
North America was the largest region in the locally advanced pancreatic cancer market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the locally advanced pancreatic cancer market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Locally Advanced Pancreatic Cancer Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Locally Advanced Pancreatic Cancer Market 2026, By The Business Research Company
Invasive Ductal Carcinoma Therapeutics Market Report 2026
Pancreatic Cancer Drugs Market Report
https://www.thebusinessresearchcompany.com/report/pancreatic-cancer-drugs-global-market-report
Gastroesophageal Junction Adenocarcinoma Therapeutics Market Report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
